Stock Market Recap: G1 Therapeutics Inc (GTHX) Concludes at 2.93, a -2.66 Surge/Decline

In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

After finishing at $3.01 in the prior trading day, G1 Therapeutics Inc (NASDAQ: GTHX) closed at $2.93, down -2.66%. In other words, the price has decreased by -$2.66 from its previous closing price. On the day, 0.58 million shares were traded. GTHX stock price reached its highest trading level at $3.06 during the session, while it also had its lowest trading level at $2.865.


Our goal is to gain a better understanding of GTHX by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.55 and its Current Ratio is at 2.94. In the meantime, Its Debt-to-Equity ratio is 1.70 whereas as Long-Term Debt/Eq ratio is at 1.48.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, JP Morgan on January 30, 2023, Upgraded its rating to Neutral and sets its target price to $10 from $7 previously.

On January 03, 2023, Needham reiterated its Buy rating and also upped its target price recommendation from $32 to $31.

JP Morgan Downgraded its Neutral to Underweight on November 04, 2021, whereas the target price for the stock was revised from $20 to $19.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 23 ’24 when Thomas Monica R. sold 5,826 shares for $4.27 per share. The transaction valued at 24,864 led to the insider holds 109,825 shares of the business.

Bailey John E. (Jack) Jr. sold 37,258 shares of GTHX for $178,421 on May 13 ’24. The President and CEO now owns 452,336 shares after completing the transaction at $4.79 per share. On May 13 ’24, another insider, MURDOCK TERRY L, who serves as the Chief Operating Officer of the company, sold 8,151 shares for $4.79 each. As a result, the insider received 39,034 and left with 95,487 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GTHX now has a Market Capitalization of 153184512 and an Enterprise Value of 135087472. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.82 while its Price-to-Book (P/B) ratio in mrq is 5.52. Its current Enterprise Value per Revenue stands at 1.607 whereas that against EBITDA is -6.05.

Stock Price History:

Over the past 52 weeks, GTHX has reached a high of $6.14, while it has fallen to a 52-week low of $1.08. The 50-Day Moving Average of the stock is -29.93%, while the 200-Day Moving Average is calculated to be 1.49%.

Shares Statistics:

The stock has traded on average 1.32M shares per day over the past 3-months and 1019270 shares per day over the last 10 days, according to various share statistics. A total of 51.93M shares are outstanding, with a floating share count of 43.00M. Insiders hold about 17.76% of the company’s shares, while institutions hold 27.51% stake in the company. Shares short for GTHX as of 1715731200 were 3587279 with a Short Ratio of 2.72, compared to 1713139200 on 2421729. Therefore, it implies a Short% of Shares Outstanding of 3587279 and a Short% of Float of 6.9299996.

Most Popular